MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $704,546 | -44.1% | 26,133 | -62.7% | 0.00% | -42.9% |
| Q3 2022 | $1,260,000 | +44.3% | 70,133 | -0.1% | 0.01% | +16.7% |
| Q2 2022 | $873,000 | -6.7% | 70,233 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $936,000 | -14.3% | 70,233 | +0.1% | 0.01% | -14.3% |
| Q4 2021 | $1,092,000 | -30.6% | 70,133 | 0.0% | 0.01% | -46.2% |
| Q3 2021 | $1,574,000 | +53.6% | 70,133 | +55.9% | 0.01% | +30.0% |
| Q2 2021 | $1,025,000 | +13.1% | 45,000 | +2.3% | 0.01% | 0.0% |
| Q1 2021 | $906,000 | -23.4% | 44,000 | +2.8% | 0.01% | -37.5% |
| Q4 2020 | $1,182,000 | +111.1% | 42,790 | +6.9% | 0.02% | +77.8% |
| Q3 2020 | $560,000 | +15.7% | 40,040 | +66.6% | 0.01% | +12.5% |
| Q2 2020 | $484,000 | +229.3% | 24,040 | +20.2% | 0.01% | +166.7% |
| Q1 2020 | $147,000 | -50.2% | 20,000 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $295,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |